142 related articles for article (PubMed ID: 12846419)
1. Incidence of anaemia in breast cancer patients receiving adjuvant chemotherapy.
Denison U; Baumann J; Peters-Engl C; Samonigg H; Krippl P; Lang A; Obermair A; Wagner H; Sevelda P
Breast Cancer Res Treat; 2003 Jun; 79(3):347-53. PubMed ID: 12846419
[TBL] [Abstract][Full Text] [Related]
2. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
Biesma B; van de Werf PR; Melissant CF; Brok RG
Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
[TBL] [Abstract][Full Text] [Related]
3. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
[TBL] [Abstract][Full Text] [Related]
4. Use of darbepoetin alfa in European clinical practice for the management of chemotherapy-induced anaemia in four tumour types: final data from the CHOICE study.
Aerts JG; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Van Belle S
Curr Med Res Opin; 2012 Jul; 28(7):1089-99. PubMed ID: 22642866
[TBL] [Abstract][Full Text] [Related]
5. Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey.
Coiffier B; Guastalla JP; Pujade-Lauraine E; Bastit P;
Eur J Cancer; 2001 Sep; 37(13):1617-23. PubMed ID: 11527686
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin in the treatment of cancer-related or chemotherapy-induced anaemia in patients with solid tumours.
Nowrousian MR
Med Oncol; 1998 Aug; 15 Suppl 1():S19-28. PubMed ID: 9785333
[TBL] [Abstract][Full Text] [Related]
7. Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer.
Bokemeyer C; Oechsle K; Hartmann JT; Schöffski P; Schleucher N; Metzner B; Schleicher J; Kanz L
Br J Cancer; 2002 Nov; 87(10):1066-71. PubMed ID: 12402143
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and management of anaemia in haematologic cancer patients receiving cyclic nonplatinum chemotherapy: results of a prospective national chart survey.
Steurer M; Wagner H; Gastl G
Wien Klin Wochenschr; 2004 Jun; 116(11-12):367-72. PubMed ID: 15291288
[TBL] [Abstract][Full Text] [Related]
9. Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer.
Thatcher N; De Campos ES; Bell DR; Steward WP; Varghese G; Morant R; Vansteenkiste JF; Rosso R; Ewers SB; Sundal E; Schatzmann E; Stocker H
Br J Cancer; 1999 May; 80(3-4):396-402. PubMed ID: 10408844
[TBL] [Abstract][Full Text] [Related]
10. Anemia profiles in patients with lung cancer: what have we learned from the European Cancer Anaemia Survey (ECAS)?
Kosmidis P; Krzakowski M;
Lung Cancer; 2005 Dec; 50(3):401-12. PubMed ID: 16191450
[TBL] [Abstract][Full Text] [Related]
11. Impact of haemoglobin levels during adjuvant chemotherapy on the survival of patients with primary breast cancer.
Peters-Engl C; Cassik P; Schmidt I; Denison U; Medl M; Pokieser W; Sevelda P
Acta Oncol; 2005; 44(2):129-33. PubMed ID: 15788291
[TBL] [Abstract][Full Text] [Related]
12. Effect of once-weekly epoetin beta on survival in patients with metastatic breast cancer receiving anthracycline- and/or taxane-based chemotherapy: results of the Breast Cancer-Anemia and the Value of Erythropoietin (BRAVE) study.
Aapro M; Leonard RC; Barnadas A; Marangolo M; Untch M; Malamos N; Mayordomo J; Reichert D; Pedrini JL; Ukarma L; Scherhag A; Burger HU
J Clin Oncol; 2008 Feb; 26(4):592-8. PubMed ID: 18235117
[TBL] [Abstract][Full Text] [Related]
13. A final analysis from the CHOICE study examining darbepoetin alfa use for chemotherapy-induced anaemia in current European clinical practice.
Van Belle S; Swieboda-Sadlej A; Karanikiotis C; Labourey JL; Galid A; Wheeler T; Pujol B; Aerts JG
Curr Med Res Opin; 2012 Jul; 28(7):1079-87. PubMed ID: 22642867
[TBL] [Abstract][Full Text] [Related]
14. RETRA: evaluating the transfusion rate with darbepoetin alfa 500 µg every 3 weeks in anaemic cancer patients receiving chemotherapy.
Eisterer W; Hussl C; Erb H; Haslbauer F; Sormann S; Braun S; Jaeger C
Curr Med Res Opin; 2011 Feb; 27(2):355-63. PubMed ID: 21166611
[TBL] [Abstract][Full Text] [Related]
15. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
Ariganello O; Mancuso A; Di Molfetta M; Diana F; Beccaglia P; Cortesi E; De Marinis F
Lung Cancer; 2004 Oct; 46(1):119-24. PubMed ID: 15364140
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008).
Verbeke N; Beguin Y; Wildiers H; Canon JL; Bries G; Bosly A; Van Belle S
Support Care Cancer; 2012 Jan; 20(1):23-8. PubMed ID: 21107613
[TBL] [Abstract][Full Text] [Related]
17. Epoetin alfa 60,000 U once weekly followed by 120,000 U every 3 weeks increases and maintains hemoglobin levels in anemic cancer patients undergoing chemotherapy.
Patton J; Kuzur M; Liggett W; Miranda F; Varsos H; Porter L
Oncologist; 2004; 9(1):90-6. PubMed ID: 14755018
[TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapy.
Chaumard N; Limat S; Villanueva C; Nerich V; Fagnoni P; Bazan F; Chaigneau L; Dobi E; Cals L; Pivot X
Breast; 2012 Aug; 21(4):464-7. PubMed ID: 22123411
[TBL] [Abstract][Full Text] [Related]
19. PREPARE: the prevalence of perioperative anaemia and need for patient blood management in elective orthopaedic surgery: a multicentre, observational study.
Lasocki S; Krauspe R; von Heymann C; Mezzacasa A; Chainey S; Spahn DR
Eur J Anaesthesiol; 2015 Mar; 32(3):160-7. PubMed ID: 25564780
[TBL] [Abstract][Full Text] [Related]
20. Weekly epoetin beta maintains haemoglobin levels and improves quality of life in patients with non-myeloid malignancies receiving chemotherapy.
Suzuki Y; Tokuda Y; Fujiwara Y; Minami H; Ohashi Y; Saijo N
Jpn J Clin Oncol; 2008 Mar; 38(3):214-21. PubMed ID: 18296425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
